Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12206
Full metadata record
DC FieldValueLanguage
dc.contributor.authorO'Callaghan, Christopher Jen
dc.contributor.authorRong, Peien
dc.contributor.authorGoh, Min Yen
dc.date.accessioned2015-05-16T01:51:42Z
dc.date.available2015-05-16T01:51:42Z
dc.date.issued2014-05-05en
dc.identifier.citationMedical Journal of Australia; 200(8): 454, 456en
dc.identifier.govdoc24794600en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12206en
dc.language.isoenen
dc.subject.otherAngiotensin Receptor Antagonists.adverse effects.therapeutic useen
dc.subject.otherAngiotensin-Converting Enzyme Inhibitors.adverse effects.therapeutic useen
dc.subject.otherAustraliaen
dc.subject.otherCardiovascular Diseases.drug therapy.prevention & controlen
dc.subject.otherDisease Managementen
dc.subject.otherDrug Therapy, Combinationen
dc.subject.otherHumansen
dc.subject.otherHypertension.drug therapyen
dc.subject.otherPractice Guidelines as Topicen
dc.subject.otherRisk Factorsen
dc.titleNational guidelines for the management of absolute cardiovascular disease risk.en
dc.typeJournal Articleen
dc.identifier.journaltitleMedical Journal of Australiaen
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australia, Australiaen
dc.description.pages454, 456en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/24794600en
dc.type.austinJournal Articleen
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.deptClinical Pharmacology and Therapeutics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Feb 6, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.